H erpes simplex virus type 2 (HSV-2) is the leading cause of genital ulcers worldwide and an important cause of neonatal morbidity and mortality. 1 Although its precise role remains unclear, 2,3 HSV-2 infection has been associated with increased risk for human immunodeficiency virus type 1 (HIV-1) transmission, likely due to genital mucosal inflammation and ulceration. 4 Because HSV-2 infection is a lifelong condition with frequent recurrences, identifying potential risk reduction strategies is important, particularly among persons at high risk for HIV-1 acquisition. 5 Risk factors for incident HSV-2 infection have been evaluated in African women who report high-risk sexual behavior, including female sex workers (FSW), in whom HSV-2 incidence is among the highest reported (up to 23 per 100 person-years). 6, 7 Several recent studies have evaluated HSV-2 acquisition risk among sexually active African men, reporting incidence rates ranging from 2.1 to 4.9 per 100 person-years. 8, 9 High-risk African men, in particular men who have sex with men (MSM) and male sex workers (MSW), have largely been neglected in the epidemic, but their role in the sexual transmission of HIV-1 in this region has received increasing attention. 10 To date, no studies have reported risk factors for HSV-2 infection among African MSM and MSW. Our aim was to identify factors associated with incident HSV-2 infection among HIV-1-seronegative MSM and MSW on the Kenyan Coast. We compare our results with an analysis of factors associated with incident HSV-2 infection among high-risk HIV-1-seronegative women, the majority FSW, in the same community.
MATERIALS AND METHODS

Study Population
In July 2005, a prospective study of men and women at high risk for HIV-1 acquisition was initiated in a clinic north of 
Clinical Procedures
Detailed procedures have been described previously. 11 Briefly, eligible persons underwent confidential HIV counseling and testing, then completed face-to-face or audio computer-assisted interviews using standardized questionnaires to ascertain recent sexual behavior and genitourinary symptoms. 12 Participants were asked how many times in the past week they had washed their genitals (for men) or washed inside the vagina (for women) with water or soap (including detergent or antiseptic). A physical examination was performed, including collection of specimens for STI screening. Genital ulcers and circumcision status were noted. A blood sample was obtained for HIV-1 serological testing, and aliquots were archived at Ϫ80°C. Screening samples were not initially stored for persons who tested HIV-1 seropositive, but were archived starting in March 2006.
Persons who tested HIV-1 seronegative were enrolled and underwent monthly (if receptive anal intercourse reported) or quarterly follow-up visits with procedures as outlined previously. HIV-1-infected persons were offered enrollment into a parallel cohort for clinical follow-up without storage of research samples. Participants with genital symptoms were provided syndromic treatment, and laboratory-diagnosed infections were treated following Kenyan Ministry of Health guidelines. At each visit, risk reduction counseling, condoms, and lubricants were provided. The study was approved by ethical review boards at the Kenya Medical Research Institute and the University of Washington. All participants provided written informed consent.
Laboratory Testing
HIV-1 testing was performed using 2 rapid test kits in parallel (Determine, Abbott Laboratories, Abbott Park, IL; Unigold, Trinity Biotech Plc, Bray, Ireland). Discrepant rapid HIV-1 test results were resolved using an enzyme-linked immunosorbent assay (ELISA) (Genetic System HIV-1/2 plus O EIA, Bio-Rad Laboratories, Redmond, WA). Incident HIV-1 infection was defined as negative serology at enrollment followed by positive serology results during follow-up period. Prevalent syphilis was diagnosed by a positive rapid plasma reagin titer confirmed by Treponema pallidum haemagglutination assay. Incident syphilis was defined as a 4-fold increase in rapid plasma reagin titer confirmed by T. pallidum haemagglutination assay.
Serological testing for HSV-2 was performed on archived samples using a type-specific ELISA (HerpeSelect-2, Focus Diagnostics, Cypress, CA), according to manufacturer's protocol. An index value of Ͼ3.5 (ratio of the optical density of the sample to that of the standard calibrator) was considered positive, in accordance with published studies on the sensitivity and specificity of HerpeSelect in East Africa. [13] [14] [15] [16] All enrollment samples were tested for HSV-2, regardless of HIV-1 serostatus. Participants who were HSV-2 seronegative and who had follow-up samples available had their last follow-up samples tested to define HSV-2 serostatus at the end of the study. For participants who were HSV-2 seropositive at their last visit, intervening samples were tested to determine the seroconversion time point. The archived enrollment samples were serum and follow-up samples were plasma. The HSV-2 ELISA used in this study provides similar results with both sample types. 17 Serologic testing was repeated on a randomly selected 10% of enrollment specimens for quality control purposes.
Data Analysis
Separate analyses were conducted for men and women. All participants with enrollment results were included for estimation of HSV-2 seroprevalence. HSV-2 prevalence for groups was compared by Pearson 2 test. Prevalence ratios were used to measure associations between potential risk factors at enrollment and prevalent HSV-2 infection. A multivariate Poisson model was used to estimate adjusted prevalence ratios.
Participants who were HSV-2 seronegative at baseline and had at least one follow-up sample available for testing through July 2009 were included in the HSV-2 incidence analysis. The date of HSV-2 infection was estimated at the midpoint between the last negative and first positive test result. Incidence rates for groups were compared by log-rank test. We evaluated potential risk factors that were fixed (e.g., demographics, circumcision status) or time-varying covariates (genital washing, alcohol use, sexual behaviors, HIV status). Incidence rate ratios (IRR) were used to measure associations between potential risk factors and HSV-2 incidence per 100 person-years of follow-up. A multivariate Poisson model was used to estimate adjusted IRR (aIRR).
Genital symptoms and examination findings (e.g., genital ulcers) were not included for modeling because they were likely a consequence, rather than a cause, of HSV-2 serostatus. Factors identified a priori (age and HIV-1 status) and factors associated with prevalent or incident HSV-2 with P Յ 0.10 were included in final multivariate modeling. We assessed the robustness of the main analysis by excluding observations with index values Ͼ1.1 and Յ3.5, [13] [14] [15] [16] as values in this range may represent early incident HSV-2 infection. 18 Stata version 11.1 (StataCorp, College Station, TX) was used for analysis. Statistical significance was evaluated at the 0.05 level.
RESULTS
Population
Between July 2005 and December 2008, 1364 adults were enrolled, of whom 1272 (93.3%) had stored samples available for HSV-2 testing (Fig. 1) . Those with no archived sample were more likely to be HIV-1 seropositive (95.5% vs. 17.0%, P Ͻ 0.001) and female (69.7% vs. 36.9%, P Ͻ 0.001). Other baseline characteristics did not differ significantly between the 2 groups.
Of the 1272 participants with enrollment samples available, 803 (63.1%) were males. Most participants were single (72.0% of men and 59.5% of women). The median age was 26 years for both genders (interquartile range, 22-33 years for men, 22-31 years for women). Few participants reported formal employment (28.1% of men and 7.3% of women). The majority reported transactional sexual work in the past 3 months (55.3% of men and 73.6% of women). Overall HIV-1 prevalence was 17.0%, and was higher in women than in men (20.9% vs. 14.7%, P ϭ 0.004).
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HSV-2 Prevalence and Risk Factors
At enrollment, 415 participants (32.6%) were HSV-2-seropositive. Prevalence was higher among women than in men (50.8% vs. 22.0%, P Ͻ 0.001). Genital ulcers were detected at a slightly higher frequency among HSV-2-seropositive compared with -seronegative participants during the enrollment examination, but these differences were not significant (3.6% vs. 3.1% for men, P ϭ 0.75; 8.8% vs. 6.4% for women, P ϭ 0.35). Among men, HSV-2 prevalence increased with increasing age, alcohol use, prevalent syphilis, and prevalent HIV-1 infection (Table 1) . There was no association between prevalent HSV-2 and male sexual orientation or sex work. Among women, HSV-2 prevalence increased with increasing age, lower educational attainment, and prevalent HIV-1 infection (Table 2 ). There was no association between prevalent HSV-2 and female sex work. Only 2 women (0.4%) reported homosexual activity.
Incidence Risk Factors
Of 857 volunteers who were HSV-2 seronegative at baseline, 607 individuals (all HIV-1 seronegative) had subsequent blood samples available for testing, contributing 767.1 person-years of follow-up. Median follow-up time was 16.8 months (interquartile range, 7.6 -21.2 months). Among participants not contributing to follow-up, 77 were HIV-1 seropositive and therefore had no stored samples, and the remaining 173 (22.2% of 780 HIV-1-seronegative participants) never returned (Fig. 1) . HIV-1-seronegative and HSV-2-seronegative participants who did not return to follow-up were younger (58.4% vs. 45.6% aged Ͻ25 years; P ϭ 0.003) and more likely to be single (80.4% vs. 69.5%, P ϭ 0.005) as compared with those retained.
The HSV-2 incidence rate during follow-up was 9.0 per 100 person-years among men (Table 3 ) and 22.1 per 100 person-years among women (Table 4) . This difference was statistically significant (P Ͻ 0.001). No incident case of syphilis occurred at the time of HSV-2 acquisition among either men or women.
Among men, HSV-2 acquisition during follow-up was associated with genital ulcer disease detected by examination (IRR, 4.3; 95% confidence interval [CI], 1.1-17.3). In multivariate analysis, HSV-2 acquisition was associated with HIV-1 acquisition (aIRR, 3.9; 95% CI, 1.3-12.4) and use of soap for genital washing was protective (aIRR, 0.3; 95% CI, 0.1-0.8). A dose-response relationship between genital washing with soap and incident HSV-2 infection could be demonstrated as follows: incidence rates were estimated at 25.9, 10.2, 8.3, and 5.7 per 100 person-years without use of soap, with use of soap Յ7 times weekly, with use of soap 8 to 14 times weekly, and with use of soap Ͼ14 times weekly, respectively. There was a significant reduction in HSV-2 incidence for every increment in the frequency of washing with soap (IRR, 0.7; 95% CI, 0.4 -1.0; P ϭ 0.03).
Because we were interested in the effect of receptive anal intercourse on HSV-2 acquisition, we tested the effect of adding this variable to the multivariate model. If receptive anal intercourse is included a priori, its association with HSV-2 acquisition is of borderline significance (aIRR, 2.0; 95% CI, 1.0 -4.1; P ϭ 0.057) and HSV-2 acquisition is no longer significantly associated with HIV-1 acquisition (aIRR, 2.6; 95% CI, 0.7-9.3; P ϭ 0.1). Soap use remains a significant predictor in this model (aIRR, 0.3; 95% CI, 0.1-0.8; P ϭ 0.01).
Among women, HSV-2 acquisition was not associated with genital ulcer disease detected by examination (aIRR, 0.6; 95% CI, 0.1-4.1). In multivariate analysis, HSV-2 acquisition was associated with incident HIV-1 infection (aIRR, 8.9; 95% CI, 3.6 -21.8) and washing inside the vagina with soap (aIRR, 1.9; 95% CI, 1.0 -3.4). There was no dose-response relationship between vaginal washing with soap and incident HSV-2 infection; incidence rates were estimated at 18.3, 37.1, 33.9, and 27.4 per 100 person-years without vaginal soap use, with soap use Յ7 times weekly, with soap use 8 to 14 times weekly, and with soap use Ͼ14 times weekly, respectively. The addition of receptive anal intercourse to the model did not change these results.
Sensitivity Analysis
In the sensitivity analysis in which HerpeSelect index values of Ͼ1.1 and Յ3.5 were excluded, associations with HSV-2 prevalence were unchanged. Power for the incidence analysis was reduced, as only seroconversions from low negative index values are included. HIV-1 remained significantly associated with incident HSV-2 infection in both men and women. Although risk estimates were similar to those from the main analysis, use of soap for vaginal washing among women (aIRR, 1.4; 95% CI, 0.4 -5.1) and for genital washing among men (0.6, 0.2-2.2) was no longer significantly associated with incident HSV-2.
DISCUSSION
The overall 32.6% HSV-2 prevalence in this cohort is close to the 35.4% national prevalence reported among Ke- nyans adults aged 15 to 64 years (42.3% among women vs. 26.1% among men). 19 In this cohort of young individuals reporting high-risk sex, women had a higher HSV-2 prevalence than men (50.8% vs. 22.0%). Although the majority of men and women in this cohort reported recent transactional sexual work, transactional sex was not associated with HSV-2 prevalence or incidence. Overall, we found somewhat lower HSV-2 prevalence than reported in similar East African populations. For example, our observed HSV-2 prevalence in men was lower than that reported among young, heterosexual men in Kisumu, Kenya (27.6%), and in a similar cohort of men in Rakai, Uganda (33.8%). 8, 20 Among women, the HSV-2 prevalence (50.8%) was lower than the 80% prevalence reported in both an FSW cohort in Mombasa, Kenya, and in female recreational facility workers (35% transactional sex workers) in northwestern Tanzania. 6, 21 We found that HSV-2 prevalence was strongly associated with increasing age and prevalent HIV-1 infection in both men and women, as reported elsewhere. 8, 19, 21 We also found that HSV-2 prevalence was associated with alcohol use, prevalent syphilis in men, and with lower educational level in women, likely reflecting a higher probability of exposure in these groups.
In this study, the HSV-2 incidence estimated in men (9.0/100 person-years) is 2 times as high as estimates for sexually active men in the general population in sub-Saharan Africa and almost 5 times higher than that reported among HSV-2 indicates herpes simplex virus type 2; HIV, human immunodeficiency virus; CI, confidence interval; PR, prevalence ratios; aPR, adjusted prevalence ratios.
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North American MSM. 8, 9, 22 The estimated incidence in women (22.1/100 person-years) is very close to that reported for an FSW cohort in the same geographic area. 6 The higher HSV-2 incidence among women in this cohort contrasts with their lower HIV-1 incidence compared with MSM in this cohort (3.2/100 person-years vs. 8.6/100 person-years). 23 Nevertheless, HSV-2 incidence was associated with incident HIV-1 infection among both men and women, as reported previously in a number of studies. 24 In our analysis of HSV-2 incidence in men, the association with HIV-1 infection was weakened after inclusion of receptive anal intercourse in the model, suggesting that the association between HSV-2 incidence and HIV-1 acquisition may be partly mediated through this high-risk behavior. Although our finding of a 2-fold increase in HSV-2 acquisition risk among men reporting receptive anal intercourse did not reach statistical significance, unprotected receptive anal intercourse has previously been reported to increase HSV-2 acquisition risk among North American MSM. 22 For many of our study participants, unprotected receptive anal intercourse may therefore be an important factor increasing risk of both HIV-1 and HSV-2 infection.
At each visit, we asked participants the number of times in the past week they had washed their genitals (for men) or inside their vagina (for women) with soap, including use of detergent or antiseptic. We found that using soap for genital hygiene was associated with a decreased risk of HSV-2 acquisition among men and an increased risk among women. There is some biologic plausibility to this finding, as the moist mucosal epithelium of the vagina may be more subject to irritation by soaps and abrasive washcloths than the keratinized squamous epithelium that protects the penis. We found a doseresponse relationship of washing with soap among the men in our study, with greater protection among those who washed more frequently. As the majority (87%) of our male participants were circumcised, we were unable to evaluate the effect of genital washing with soap in uncircumcised men, who may have increased vulnerability to genital infections. 25 Among women, washing inside the vagina with soap was associated with higher HSV-2 acquisition risk, but no dose-response relationship was apparent. Vaginal washing, especially washing with soap, has been associated with increased HIV-1 acquisition risk among Kenyan women after adjustment for demographic factors, sexual behavior, and genital infections including bac- HSV-2 indicates herpes simplex virus type 2; HIV, human immunodeficiency virus; CI, confidence interval; PR, prevalence ratios; aPR, adjusted prevalence ratios.
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Sexually Transmitted Diseases • Volume 38, Number 12, December 2011 terial vaginosis. 26 Although the frequency of vaginal douching was associated with recent HSV-2 infection among women in one African study, 21 another study reported no association between vaginal washing and HSV-2 acquisition. 6 The associations we found between genital washing with soap, detergent, or antiseptic and HSV-2 acquisition in both sexes are intriguing, but were not robust in the sensitivity analysis and require validation.
To our knowledge, this is the first prospective study to evaluate risk factors for incident HSV-2 infection in African men reporting high-risk sexual behaviors. This strength should be considered in the context of a number of important limita- Condom use for anal sex in the past 3 months is omitted because there was only 1 event (in a woman reporting always using condoms for anal sex), and the model would not converge. *Among women reporting any type of sex. HSV-2 indicates herpes simplex virus type 2; HIV, human immunodeficiency virus; CI, confidence interval; IRR, incidence rate ratios; PY, patient-years.
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tions. First, our sample size and follow-up duration were limited, especially for women. Second, we were unable to confirm HSV-2 seroconversions with Western blot testing due to budgetary constraints. However, the HerpeSelect assay has optimal sensitivity and specificity at an index value of 3.4 to 3.5, and we conducted a sensitivity analysis to evaluate the extent to which results were affected by possible misclassification of early incident HSV-2 infection. 18 Third, our risk behavior assessments are based on self-report, with the majority taking place on a quarterly basis. Therefore, recall and social desirability bias, as well as measurement error due to the relatively long interval between visits, are a likely source of residual confounding. 12 Finally, loss to follow-up in this mobile population is relatively high and may affect our risk estimates. We have detected a very high incidence of HSV-2 acquisition among the men and women in this study, among the highest reported for each sex to date. We have confirmed that HSV-2 risk is strongly intertwined with that for HIV-1, another sexually transmitted viral infection with life-long consequences. These findings reinforce the need for promotion of safe sex as the primary method for the prevention of both HSV-2 and HIV-1 infections, as well as other STIs. While the role of genital hygiene in HSV-2 acquisition is yet unclear, women should avoid vaginal washing so as to lower their risk of HIV-1 acquisition, 26, 27 and our results suggest an added benefit in terms of HSV-2 prevention. In addition, men may benefit in many ways from good hygiene, including washing their genitals with soap. However, a specific recommendation to have men wash their genitals with soap to prevent HSV-2 acquisition would be premature.
